Virtus LifeSci Biotech Clinical Trials ETF
11 hedge funds and large institutions have $8.61M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.45M | |
| 2 | +$1.13M | |
| 3 | +$203K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$80K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$22.5K |
Top Sellers
| 1 | -$3.62M | |
| 2 | -$40.2K | |
| 3 | -$8.14K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$7K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$5.61K |